Personalized medicine
DATABASE (51)
ARTICLES (97)
The Bank of China is one of four major state-owned banks in China. It provides financial services to China as well as 51 other countries and regions. The BOC makes direct investments and conducts investment management through its wholly owned subsidiary Bank of China Group Investment Ltd. It invests primarily in its clients and focuses on the fields of finance, consumption, medicine and energy sources.
The Bank of China is one of four major state-owned banks in China. It provides financial services to China as well as 51 other countries and regions. The BOC makes direct investments and conducts investment management through its wholly owned subsidiary Bank of China Group Investment Ltd. It invests primarily in its clients and focuses on the fields of finance, consumption, medicine and energy sources.
WuXi AppTec is a Chinese company that specializes in the outsourcing of R&D in the pharmaceuticals, biotechnology and medical devices sectors. Listed on the Hong Kong Stock Exchange, WuXi AppTec has invested in drug development and healthcare firms globally. Its portfolio includes Insilico Medicine, which is developing an AI platform for drug development, brain disease research firm Verge Genomics and Indonesian healthcare platform Halodoc.
WuXi AppTec is a Chinese company that specializes in the outsourcing of R&D in the pharmaceuticals, biotechnology and medical devices sectors. Listed on the Hong Kong Stock Exchange, WuXi AppTec has invested in drug development and healthcare firms globally. Its portfolio includes Insilico Medicine, which is developing an AI platform for drug development, brain disease research firm Verge Genomics and Indonesian healthcare platform Halodoc.
Halodoc's unified platform brings thousands of doctors, pharmacies and testing laboratories into easy reach of Indonesians looking to conveniently access essential healthcare services.
Halodoc's unified platform brings thousands of doctors, pharmacies and testing laboratories into easy reach of Indonesians looking to conveniently access essential healthcare services.
“Can’t buy your medication? Order from ProSehat!” The online healthcare supermart will source and deliver prescriptions faster and cheaper than downtown pharmacies.
“Can’t buy your medication? Order from ProSehat!” The online healthcare supermart will source and deliver prescriptions faster and cheaper than downtown pharmacies.
Through crowdfunding, Chinese insurtech firm Waterdrop makes treatment for critical diseases accessible to the majority of China's population who have no commercial health insurance.
Through crowdfunding, Chinese insurtech firm Waterdrop makes treatment for critical diseases accessible to the majority of China's population who have no commercial health insurance.
Kingfisher is a privately owned, and independently managed financial services firm active for nearly three decades. The firm was established in Charlotte in the US in 1989 and acquired by WealthTrust, LLC in 2004. In 2009, it returned to operate as an independent investment adviser under the name of Kingfisher Capital, LLC and purchased all outstanding ownership interest from WealthTrust LLC. Kingfisher has supported affluent families, professionals, business owners, and institutions through financial advisory, smart investments and personalized client service.The firm is currently led by managing partners and co-founders Alexander Miles and H K Hallett. Prior to founding Kingfisher, Miles worked at WealthTrust Advisors, the Myers Limited Partnerships and Lehman Brothers in New York. Hallett worked for Trust Company Bank of Georgia and Peoples Bank of North Carolina before joining Carolina Securities Corporation, where he co-managed the Charlotte office.
Kingfisher is a privately owned, and independently managed financial services firm active for nearly three decades. The firm was established in Charlotte in the US in 1989 and acquired by WealthTrust, LLC in 2004. In 2009, it returned to operate as an independent investment adviser under the name of Kingfisher Capital, LLC and purchased all outstanding ownership interest from WealthTrust LLC. Kingfisher has supported affluent families, professionals, business owners, and institutions through financial advisory, smart investments and personalized client service.The firm is currently led by managing partners and co-founders Alexander Miles and H K Hallett. Prior to founding Kingfisher, Miles worked at WealthTrust Advisors, the Myers Limited Partnerships and Lehman Brothers in New York. Hallett worked for Trust Company Bank of Georgia and Peoples Bank of North Carolina before joining Carolina Securities Corporation, where he co-managed the Charlotte office.
Co-founder of Dingdang Medicine Express
Xu Huansheng was born in 1979 and obtained an MBA from the National School of Development, Peking University. He founded Baidu’s smart hardware unit and Baidu Cloud during his four years at Baidu in the early 2010s. He co-founded Dingdang Medicine Express in 2014. He is now a senior partner at Feihe Dairy (Firmus), one of the biggest infant and toddler formula producers in China.
Xu Huansheng was born in 1979 and obtained an MBA from the National School of Development, Peking University. He founded Baidu’s smart hardware unit and Baidu Cloud during his four years at Baidu in the early 2010s. He co-founded Dingdang Medicine Express in 2014. He is now a senior partner at Feihe Dairy (Firmus), one of the biggest infant and toddler formula producers in China.
Silicon Valley Future Capital is a venture capital firm that invests primarily in early stage and growth stage companies with disruptive technologies or innovative business models. Founding partner Dr. Hong Miao used to be managing partner of CLI Ventures, senior VP of CheerLand Investment Group, executive president of the CL Institute of Innovation, and chairman of Zen Water Capital in Silicon Valley. The firm invests primarily in innovations in high-tech, including artificial intelligence, machine learning, big data, cloud computing, robotics, life science, biotech, precision medicine and other disruptive technologies.
Silicon Valley Future Capital is a venture capital firm that invests primarily in early stage and growth stage companies with disruptive technologies or innovative business models. Founding partner Dr. Hong Miao used to be managing partner of CLI Ventures, senior VP of CheerLand Investment Group, executive president of the CL Institute of Innovation, and chairman of Zen Water Capital in Silicon Valley. The firm invests primarily in innovations in high-tech, including artificial intelligence, machine learning, big data, cloud computing, robotics, life science, biotech, precision medicine and other disruptive technologies.
Asabys Partners is a VC firm based in Barcelona and invests mainly in the healthtech and biopharma industries. Backed by Sabadell Bank, the VC now has offices in Spain, UK, Switzerland and Israel. Asabys Partners aims to accelerate technology breakthroughs in the fields of science and medicine by supporting a network of industry experts and talent.Asabys started operations in 2019 and is currently fundraising its first fund, Sabadell Asabys Health Innovation Investments, with a target size of €70m and Banc Sabadell as anchor investor. Main areas of investment include Biopharma, MedTech and Digital Therapeutics.
Asabys Partners is a VC firm based in Barcelona and invests mainly in the healthtech and biopharma industries. Backed by Sabadell Bank, the VC now has offices in Spain, UK, Switzerland and Israel. Asabys Partners aims to accelerate technology breakthroughs in the fields of science and medicine by supporting a network of industry experts and talent.Asabys started operations in 2019 and is currently fundraising its first fund, Sabadell Asabys Health Innovation Investments, with a target size of €70m and Banc Sabadell as anchor investor. Main areas of investment include Biopharma, MedTech and Digital Therapeutics.
Co-founder of Meatable
Mark Kotter is the Austrian co-founder at Dutch cell-based meat startup Meatable, the first to use pluripotent stem cells and claim a highly scalable culture technology, which was developed by Kotter prior to founding the startup in 2018. He is also founder at his biotech startup, bit.bio, which is based in Cambridge, UK, since 2016, where he applies his cellular technological innovation to human stem cell research and has raised investments totaling $42m. His main full-time position is at the University of Cambridge, where he has worked since 2009. He has spent more than five years as a clinician-scientist in stem cell research and was previously a lecturer in neurosurgery. Kotter also lectures at Paris Descartes University and is a team leader at the UK’s National Institute for Health Research’s Brain Injury MedTech Co-operative. He also founded Myelopathy.org to raise awareness of cervical myelopathy. His past positions were as a research group leader at the Max Planck Institute for Experimental Medicine for one year, and for two years spent at the Medical University of Vienna. Kotter holds two doctorates; one in philosophy from the University of Cambridge and the other in medicine from the University of Graz in Austria. Kotter also holds a master’s in philosophy from the University of Cambridge.
Mark Kotter is the Austrian co-founder at Dutch cell-based meat startup Meatable, the first to use pluripotent stem cells and claim a highly scalable culture technology, which was developed by Kotter prior to founding the startup in 2018. He is also founder at his biotech startup, bit.bio, which is based in Cambridge, UK, since 2016, where he applies his cellular technological innovation to human stem cell research and has raised investments totaling $42m. His main full-time position is at the University of Cambridge, where he has worked since 2009. He has spent more than five years as a clinician-scientist in stem cell research and was previously a lecturer in neurosurgery. Kotter also lectures at Paris Descartes University and is a team leader at the UK’s National Institute for Health Research’s Brain Injury MedTech Co-operative. He also founded Myelopathy.org to raise awareness of cervical myelopathy. His past positions were as a research group leader at the Max Planck Institute for Experimental Medicine for one year, and for two years spent at the Medical University of Vienna. Kotter holds two doctorates; one in philosophy from the University of Cambridge and the other in medicine from the University of Graz in Austria. Kotter also holds a master’s in philosophy from the University of Cambridge.
Mayfield Fund is one of Silicon Valley's oldest venture capital firms. Founded by Wally Davis and Thomas J Davis Jr in 1969, the VC is based in Menlo Park, California.Current investments include CRISPR-focused companies like Mammoth Biosciences and biotech startup iLoF,l which is focused on creating a digital library of optical fingerprints for non-invasive patient screening, early diagnostics and personalized medical treatments.. With a total of $2.5bn assets under management, the firm focuses mainly on early-stage to growth-stage investments. The VC has also backed startups like Marketo, Lyft and SolarCity. Most of Mayfield’s exits took place during the 2008 financial crisis and through subsequent funds.In April 2020, amid the Covid-19 pandemic, Mayfield announced two new funds which raised $750m in total. Mayfield XVI will invest in early-stage companies, while Mayfield Select II will focus on growth-stage companies outside its portfolio. The company said last year that it has raised a similar size fund every four years and has invested in 30 companies per fund. It primarily leads Series A investments.
Mayfield Fund is one of Silicon Valley's oldest venture capital firms. Founded by Wally Davis and Thomas J Davis Jr in 1969, the VC is based in Menlo Park, California.Current investments include CRISPR-focused companies like Mammoth Biosciences and biotech startup iLoF,l which is focused on creating a digital library of optical fingerprints for non-invasive patient screening, early diagnostics and personalized medical treatments.. With a total of $2.5bn assets under management, the firm focuses mainly on early-stage to growth-stage investments. The VC has also backed startups like Marketo, Lyft and SolarCity. Most of Mayfield’s exits took place during the 2008 financial crisis and through subsequent funds.In April 2020, amid the Covid-19 pandemic, Mayfield announced two new funds which raised $750m in total. Mayfield XVI will invest in early-stage companies, while Mayfield Select II will focus on growth-stage companies outside its portfolio. The company said last year that it has raised a similar size fund every four years and has invested in 30 companies per fund. It primarily leads Series A investments.
CTO and co-founder of Knokcare (formerly Knok Healthcare)
João Magalhães is the Portuguese co-founder and CTO of medtech Knokcare, previously known as Knok Healthcare. Prior to founding Knokcare in 2015, he co-founded Iterar, a software developer that also created Knokcare’s software.Magalhães completed a master’s degree in Medicine at the University of Porto in 2014 that helped him to conceive the concept for Knokcare. He worked at Iterar for six years as a web and Android developer until 2017. He also worked in software development and systems administration at Savant for almost two years, while expanding his client portfolio at Iterar.
João Magalhães is the Portuguese co-founder and CTO of medtech Knokcare, previously known as Knok Healthcare. Prior to founding Knokcare in 2015, he co-founded Iterar, a software developer that also created Knokcare’s software.Magalhães completed a master’s degree in Medicine at the University of Porto in 2014 that helped him to conceive the concept for Knokcare. He worked at Iterar for six years as a web and Android developer until 2017. He also worked in software development and systems administration at Savant for almost two years, while expanding his client portfolio at Iterar.
East Ventures-backed microbiome personalized skincare firm is also known for helping produce Indonesia's first Covid-19 test kit, as part of state R&D collaboration.
East Ventures-backed microbiome personalized skincare firm is also known for helping produce Indonesia's first Covid-19 test kit, as part of state R&D collaboration.
Seeking to reinvigorate higher education across Latin America, aligning it with global systems, Blox’s latest deal with Pearson Education will boost its expansion.
Seeking to reinvigorate higher education across Latin America, aligning it with global systems, Blox’s latest deal with Pearson Education will boost its expansion.
Squirrel AI's adaptive learning system lets students study at their own pace while targeting their weaknesses, achieving 5–10 times greater efficacy than conventional schools.
Squirrel AI's adaptive learning system lets students study at their own pace while targeting their weaknesses, achieving 5–10 times greater efficacy than conventional schools.
iLoF: Accelerating access to personalized medicine, from a drop of blood
Backed by Microsoft’s venture fund M12, Mayfield and Melinda Gates’s Pivotal Ventures, iLoF focuses on painless screening to facilitate disease detection, forecasting and drug development, from Alzheimer’s to Covid-19
SWITCH Singapore 2021: Benefits and challenges of AI applications in healthcare
Medical experts and healthcare startups agree AI can contribute more to healthcare beyond improving diagnosis and personalized treatment, but hurdles still remain
ARTICARES: Personalized, more affordable arm rehab therapy at home
Using adaptive AI, its H-Man robot works like an occupational therapist, assessing patient’s performance and adjusting the complexity of training tasks in real time
Spain's 3D printing revolution to drive various sectors' growth
From medical splints to meat-free burgers, multimillion-dollar 3D tech hubs are spawning new verticals across Spain
Aimentia: Pioneering mental health AI SaaS seeks to improve diagnosis as demand surges
Barcelona-based Aimentia supports the oft-overlooked mental health segment through digitalization and analytics, going beyond therapy platforms
More Asian men are into skincare and health products, and Elio is here to help (discreetly)
Elio believes offering privacy, free online consultations and discreet product packaging will encourage more men to take better care of their health
In-store robots and online doctors serve customers 24/7 at Dingdang Medicine Express
Dingdang also offers cheaper medicines and 28-minute home delivery, thanks to its innovative logistics and partnership models
Spanish startups and investors rethink strategies as Covid-19 hits funding, valuations
Investors and startups in Spain say most funding has stalled, and share their strategies and advice for coping with the downturn
Lesielle: Award-winning personalized cosmetics that adapt to changing skincare needs
This Spanish AI-powered device combines with a mobile app to track the daily condition of your skin and tailor-make cosmetics for each customer
Squirrel AI: Edtech's AI-based personalized tutoring eases load for students and teachers
Used by more than 3m students, unicorn Squirrel AI tracks learning outcomes in real time and adapts teaching, proving more effective than traditional methods
China's WeDoctor offers free coronavirus consultations globally in English and Chinese
WeDoctor lets anyone in the world send queries to doctors who fought to save lives in China's most affected Covid-19 districts, and now helping people overseas to stay safe during the pandemic
TMiRob's medical robots lighten the load of doctors and nurses in hospitals
The robots also reach an operating room three minutes faster than human nurses – that's more time for saving lives
Indonesian edtechs attract funding even as students head back to school
With services that complement and support conventional schools at a fraction of offline tuition cost, edtech companies are likely to continue growing
China edtech companies pivot to survive private tutoring crackdown
AI adaptive personalized learning is the bright star, attracting investors and corporates
UpHill: Helping doctors put the latest research into practice
Born out of practitioners’ difficulty in keeping up with latest treatments and protocols, UpHill now includes guidance on Covid-19
Sorry, we couldn’t find any matches for“Personalized medicine”.
